Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers
Clinical trial NCT01932242 · COMPLETED
Trial details
- NCT number
- NCT01932242
- Sponsor
- Elusys Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-23
- Primary completion
- 2014-04-19
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.